Matches in Wikidata for { <http://www.wikidata.org/entity/Q91824253> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q91824253 description "article scientifique publié en 2018" @default.
- Q91824253 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91824253 description "scientific article published on 27 September 2018" @default.
- Q91824253 description "wetenschappelijk artikel" @default.
- Q91824253 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91824253 name "MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity" @default.
- Q91824253 name "MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity" @default.
- Q91824253 type Item @default.
- Q91824253 label "MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity" @default.
- Q91824253 label "MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity" @default.
- Q91824253 prefLabel "MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity" @default.
- Q91824253 prefLabel "MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity" @default.
- Q91824253 P1433 Q91824253-D7CF9E98-F3A7-4A64-A36B-AB490CF77BB8 @default.
- Q91824253 P1476 Q91824253-BE2EB52F-16EC-4C16-B38D-73F5699D2AB6 @default.
- Q91824253 P2093 Q91824253-069FE888-B977-4794-B958-6DFCA2DAFB0D @default.
- Q91824253 P2093 Q91824253-06E22FE9-E53A-47F7-98AF-A867D96D51FB @default.
- Q91824253 P2093 Q91824253-13A320F0-627A-4D3F-A58B-9384C9A154A1 @default.
- Q91824253 P2093 Q91824253-1C5828E4-3076-47EA-96E9-06294384D854 @default.
- Q91824253 P2093 Q91824253-20E972F2-48CA-411F-AC44-F3AD5FE51190 @default.
- Q91824253 P2093 Q91824253-42FD5970-23EA-44A4-8C62-43FD9F4F3048 @default.
- Q91824253 P2093 Q91824253-795EB762-35C1-4E9E-A6E4-7CFA5B4787A4 @default.
- Q91824253 P2093 Q91824253-828BCF2D-0858-4024-9F9A-DBC0F4C6F959 @default.
- Q91824253 P2093 Q91824253-8B00A636-6019-42E6-B6F3-7FA116B69355 @default.
- Q91824253 P2093 Q91824253-9DA44C64-14AA-4CF3-8ADF-B03E5644D6CD @default.
- Q91824253 P2093 Q91824253-A4A3D822-BBD6-4F38-AF58-635FBFE7DEAA @default.
- Q91824253 P2093 Q91824253-AEC80B8D-DDAD-4B4D-865F-1AFFBA8C7BEE @default.
- Q91824253 P2093 Q91824253-B8A2C402-EE66-428F-8997-F0C8467E5E11 @default.
- Q91824253 P2093 Q91824253-D4EA8C87-9768-4821-A705-68A20C78AF3C @default.
- Q91824253 P2093 Q91824253-E5905D58-059C-4C7E-96FF-BAB233AA218D @default.
- Q91824253 P2093 Q91824253-FBD47E1F-62C0-48D0-8D0F-23DE993A0980 @default.
- Q91824253 P2860 Q91824253-8E46EB94-610E-45F1-824F-9CE161C52D9F @default.
- Q91824253 P304 Q91824253-DB0B4A5E-6459-443C-BFF4-675D936F456C @default.
- Q91824253 P31 Q91824253-AA53BAE1-837D-40F2-83D2-5F2AA8F16492 @default.
- Q91824253 P356 Q91824253-969707D0-21DE-4AB7-9A34-AFB3517E4058 @default.
- Q91824253 P433 Q91824253-62210BF0-2F00-4252-8713-7F92D5490A1D @default.
- Q91824253 P478 Q91824253-69BFCBEC-CD7F-4E8E-8F0B-B6B6C7B08DA5 @default.
- Q91824253 P577 Q91824253-E4D8425F-F933-4A7C-9FD9-43712E2B54B1 @default.
- Q91824253 P698 Q91824253-CFEE55C7-4321-47D1-AC10-5C6085356460 @default.
- Q91824253 P356 1535-7163.MCT-17-1215 @default.
- Q91824253 P698 30262588 @default.
- Q91824253 P1433 Q2363144 @default.
- Q91824253 P1476 "MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity" @default.
- Q91824253 P2093 "Andrew Z Milinichik" @default.
- Q91824253 P2093 "Arielle C Verdi" @default.
- Q91824253 P2093 "Christopher J Maddage" @default.
- Q91824253 P2093 "Danielle Fernando" @default.
- Q91824253 P2093 "Earl F Albone" @default.
- Q91824253 P2093 "Frank Fang" @default.
- Q91824253 P2093 "Jing Li" @default.
- Q91824253 P2093 "Katherine A Rybinski" @default.
- Q91824253 P2093 "Keigo Tanaka" @default.
- Q91824253 P2093 "Keiji Furuuchi" @default.
- Q91824253 P2093 "Luigi Grasso" @default.
- Q91824253 P2093 "Megan Kuc" @default.
- Q91824253 P2093 "Shawn Fernando" @default.
- Q91824253 P2093 "Toshimitsu Uenaka" @default.
- Q91824253 P2093 "Utpal Majumder" @default.
- Q91824253 P2093 "Xin Cheng" @default.
- Q91824253 P2860 Q62773345 @default.
- Q91824253 P304 "2665-2675" @default.
- Q91824253 P31 Q13442814 @default.
- Q91824253 P356 "10.1158/1535-7163.MCT-17-1215" @default.
- Q91824253 P433 "12" @default.
- Q91824253 P478 "17" @default.
- Q91824253 P577 "2018-09-27T00:00:00Z" @default.
- Q91824253 P698 "30262588" @default.